Russell Frank Company’s Quest Diagnostics DGX Stock Holding History

Russell Frank Company’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$22M	Buy	307,378 +7,120	+2%	+$477K	0.04%	535
2015 Q4	$21.5M	Sell	300,258 -145,687	-33%	-$9.79M	0.04%	529
2015 Q3	$27.4M	Buy	445,945 +127,998	+40%	+$8.95M	0.05%	416
2015 Q2	$23.1M	Buy	317,947 +5,976	+2%	+$441K	0.04%	560
2015 Q1	$24M	Sell	311,971 -142,842	-31%	-$10.2M	0.04%	486
2014 Q4	$29.1M	Sell	454,813 -13,252	-3%	-$836K	0.05%	415
2014 Q3	$28.4M	Buy	468,065 +41,812	+10%	+$2.58M	0.05%	413
2014 Q2	$26.3M	Sell	426,253 -84,457	-17%	-$4.95M	0.05%	449
2014 Q1	$29.6M	Buy	510,710 +21,815	+4%	+$1.17M	0.05%	402
2013 Q4	$25.6M	Buy	488,895 +170,422	+54%	+$10.1M	0.05%	455
2013 Q3	$19.7M	Sell	318,473 -387,119	-55%	-$23.2M	0.03%	559
2013 Q2	$42.8M	Buy	+705,592	New	+$42M	0.08%	294

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Russell Frank Company's DGX Position: Q1 2016 in Review

Russell Frank Company increased its Quest Diagnostics (DGX) stake by 2.4% in Q1 2016, buying an estimated $477K and bringing the position to 307,378 shares worth $22M. The position accounts for 0.04% of the portfolio, ranked #535.

Russell Frank Company first reported a position in DGX in Q2 2013 and has held it in 12 quarters since. The position peaked at $42.8M in Q2 2013. 557 funds tracked by Wall St. Rank hold DGX as of Q1 2016.

Russell Frank Company held 307,378 shares of Quest Diagnostics worth $22M as of Q1 2016.
Russell Frank Company bought 7,120 Quest Diagnostics shares in Q1 2016, an estimated $477K.
Quest Diagnostics made up 0.04% of Russell Frank Company's portfolio in Q1 2016, its #535 holding.
Russell Frank Company first reported a position in Quest Diagnostics in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Quest Diagnostics position peaked at $42.8M in Q2 2013.
557 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.